Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincenza Vigorito

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Seminars in Cancer Biology|August 19, 2019
Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasisSimona Romano, Martina Tufano, Paolo D'Arrigo, et al.
Current Medicinal Chemistry|November 7, 2018
Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint MoleculesPaolo D'Arrigo, Martina Tufano, Anna Rea, et al.
EMBO Reports|October 27, 2023
PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availabilityMatteo Burigotto, Vincenza Vigorito, Colin Gliech, et al.
British Journal of Cancer|April 23, 2020
Alternative macrophage polarisation associated with resistance to anti-PD1 blockade is possibly supported by the splicing of FKBP51 immunophilin in melanoma patientsTeresa Troiani, Emilio Francesco Giunta, Martina Tufano, et al.
Cell Death Discovery|October 5, 2019
The splicing FK506-binding protein-51 isoform plays a role in glioblastoma resistance through programmed cell death ligand-1 expression regulationPaolo D'Arrigo, Marina Digregorio, Simona Romano, et al.
Science Advances|October 30, 2024
Caspase-2 kills cells with extra centrosomesDario Rizzotto, Vincenza Vigorito, Patricia Rieder, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Seminars in Cancer Biology|August 19, 2019
Cell stemness, epithelial-to-mesenchymal transition, and immunoevasion: Intertwined aspects in cancer metastasisSimona Romano, Martina Tufano, Paolo D'Arrigo, et al.
Current Medicinal Chemistry|November 7, 2018
Manipulation of the Immune System for Cancer Defeat: A Focus on the T Cell Inhibitory Checkpoint MoleculesPaolo D'Arrigo, Martina Tufano, Anna Rea, et al.
EMBO Reports|October 27, 2023
PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availabilityMatteo Burigotto, Vincenza Vigorito, Colin Gliech, et al.
British Journal of Cancer|April 23, 2020
Alternative macrophage polarisation associated with resistance to anti-PD1 blockade is possibly supported by the splicing of FKBP51 immunophilin in melanoma patientsTeresa Troiani, Emilio Francesco Giunta, Martina Tufano, et al.
Cell Death Discovery|October 5, 2019
The splicing FK506-binding protein-51 isoform plays a role in glioblastoma resistance through programmed cell death ligand-1 expression regulationPaolo D'Arrigo, Marina Digregorio, Simona Romano, et al.
Science Advances|October 30, 2024
Caspase-2 kills cells with extra centrosomesDario Rizzotto, Vincenza Vigorito, Patricia Rieder, et al.
Pageof 1